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Objective: The aim of the study was to compare the short-term donor
outcomes of laparoscopic left lateral sectionectomy (LLLS) for adult to
child living donor liver transplantation (A-C LDLT) and laparoscopic donor
nephrectomy (LDN).
Background: Although laparoscopy has become the standard approach in
kidney donors, its use remains limited and controversial in LLS for A-C LDLT
due to the lack of conclusive assessment of procedure-related morbidity.
Methods: From 2001 to 2014, 124 healthy donors undergoing laparoscopic
LLLS for A-C LDLT at 5 tertiary referral centers in Europe, North America,
and Asia, and 300 healthy donors undergoing LDN at 2 tertiary centers in
Europewere retrospectively analyzed. The outcomes of LLLSwere compared
with those of LDN including the use of the comprehensive complication index
(CCI).
Results: Although liver donors experienced significantly less overall (16.9%
vs 31.7%, P¼ 0.002) and grade 1 to 2 (12.1% vs 24.7%, P¼ 0.004)
complications than kidney donors, the rates of major complication ( grade
3) were similar between the 2 groups. In both groups, donors experiencing
postoperative complications had similar CCI (19.3 vs 21.9 for liver and kidney
donors, respectively, P¼ 0.29). After propensity score analysis allowing for
matching donors on age, sex, and body mass index, the postoperative out-
comes remained comparable between the 2 groups.
Conclusion: Laparoscopic LLS for A-C LDLT yields at least similar short-
term donor outcomes as LDN. These results provide the first validation for a
laparoscopic donor hepatectomy and suggest that the laparoscopic approach
should be considered a new standard practice for retrieval of left lateral
section liver grafts as it is for kidney donation.
Keywords: kidney live donor, laparoscopy, liver live donor, liver transplanta-
tion, surgery complications
(Ann Surg 2015;262:757–763)
A dult-to-child live donor liver transplantation (A-C LDLT) hasshown similar or even better results than deceased donor liver
transplantation in pediatric recipients.1–4 In most cases, A-C LDLT
uses left lateral section grafts. Laparoscopic left lateral sectionec-
tomy (LLLS) has been first reported in 20025 but has remained
limited to highly specialized centers, and controversial due to the
lack of conclusive assessment of procedure morbidity.6–8 We
recently reported a larger cohort of laparoscopic donor hepatecto-
mies including both LLS and left hepatectomies focusing on the
feasibility and development of the laparoscopic technique in a single
center.9 This series, however, failed to validate the technique due to
the absence of a control group. During the Second International
Consensus Conference on laparoscopic liver resection held in Mor-
ioka, Japan, in October 2014,10 a session was dedicated to laparo-
scopic donor hepatectomy (LDH). The Jury found no difference
between open and laparoscopic surgery regarding donor safety, but
the quality of evidence was considered low, not only because of the
absence of randomized study but also the lack of convincing data on
postoperative morbidity and a control group, and therefore, a call was
made for further more conclusive comparative studies.10
Laparoscopic donor nephrectomy (LDN) has become standard
practice in live kidney donors, as randomized studies and meta-
analyses have demonstrated advantages of minimally invasive
surgery, when compared with the open route.11–14 This well-
accepted technique has even contributed to a significant increase
in kidney donation rate.15
After the Consensus Conference of Morioka,10 a collaborative
group decided to assess the outcome of LLLS for pediatric trans-
plantation, comparing it with the widely accepted LDN using a
modern tool of morbidity assessment, the comprehensive compli-
cation index (CCI),16 based on the Clavien-Dindo classification of
complications.17 The aim of this retrospective study was to report the
results of a multi-institutional series of LLLS for A-C LDLT and
evaluate its short-term outcomes in reference to the LDN, a validated
procedure considered standard practice in kidney donation.
METHODS
Study Design
The collaborative consortium included the following liver
transplant centers: Paris, France (Cochin-St Antoine Hospital),
Lyon, France (E. Herriot Hospital), New York, USA (Columbia
Presbyterian Medical Center), Seoul, Korea (ASAN Medical
Center), and Ghent, Belgium (Ghent University Hospital). We
analyzed the data from living donors, who underwent LLLS from
2001 to 2014. The following donor data were obtained from pro-
spectively maintained databases: age, sex, body mass index (BMI),
American Society of Anesthesiology (ASA) score, need for con-
version into laparotomy, surgery duration, estimated blood loss,
allogeneic red blood cell transfusion, hospital stay duration,
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number, and nature of postoperative complications according to the
Clavien–Dindo (CD) classification.17 Minor complications were
defined as grade I to II, whereasmajor ones were defined as grade III
to V complications.
The control group included kidney donors operated in 2
transplant centers in Zurich, Switzerland (University Hospital Zur-
ich), and London, UK (Guy’s Hospital) between 2009 and 2014. The
donor data included age, sex, BMI, ASA score, need for conversion,
surgery duration, hospital stay duration, and occurrence of post-
operative complications according to the Clavien–Dindo system.
Live Donor Hepatectomy
All liver donors were healthy relatives, who had undergone
complete preoperative work-up, including cardiac, pulmonary, and
renal assessment, psychiatric evaluation, screening for infectious
diseases, and coagulation disorders. Liver studies included ultra-
sound, computed tomographic scanner, and magnetic resonance
imaging of the liver. Donors gave their informed consent and fulfilled
local legal and administrative requirements. The pure laparoscopic
technique was previously described by some of us.5–9 In brief, the
liver donor was in the supine position with his legs apart. Five trocars
were used in the majority of cases with a CO2 pneumoperitoneum
maintained at 12 mm Hg. The left lateral section was mobilized and
the left hepatic artery and left portal vein were dissected and taped.
Liver transection was performed on the right side of the umbilical
fissure using a combination of ultrasonic dissector, bipolar coagu-
lation, harmonic scalpel, vessels sealing devices, and clips according
to the surgeon’s preferences. After reaching the hilar plate, the left
bile duct(s) was cut and the stump on the donor side was either
clipped or sutured. Cholecystectomy and intraoperative cholangiog-
raphy were not routinely performed. At the end of parenchymal
section, the left hepatic vein was dissected free and taped. The vessels
were then closed using either clips or vascular staplers and the liver
graft was placed in a large bag, externalized through a suprapubic
incision, weighed, and immediately flushed with cold preservation
solution. Fascia was closed for incisions at least 1 cm and skin closed
with subcutaneous sutures.
After surgery, donors received prophylactic doses of low-
molecular-weight heparin for the prevention of deep vein thrombosis
for 1 month, as well as proton pump inhibitors for prevention of
peptic ulcers.
Live Donor Nephrectomy
The technique has been described previously elsewhere.18 In
brief, the kidney donor was in the lateral decubitus position. The
access was either transperitoneal or retroperitoneal according to
surgeon’s choice, using either a hand-assisted or full laparoscopic
technique. The optics and camera as well as 2 to 4 additional trocars
were placed under visual control. The technique included the mobil-
ization of the kidney, identification of the ureter, and dissection of the
renal vein and artery. The ureter was then divided using a secured
clip. The artery and veins were transected using a linear vascular
stapler. The kidney was placed in a bag and retrieved either through a
separate incision or a hand port. Fascia was closed for incisions at
least 1 cm and skin closed with subcutaneous sutures.
Postoperative Outcomes
The primary outcome of this retrospective study was the CCI,
which is a score designed and developed to take into consideration all
complications occurring after a surgical procedure, and based on the
CD classification of complications.17 The mathematical formula and
validation of this score have previously been published.16,19 In the
present study, the CCI was calculated for the whole donor cohort
using the following website: http://www.assessurgery.com/.
Statistical Analysis
Quantitative variables were expressed as mean (1 standard
deviation) or as median (range) where appropriate. Qualitative vari-
ables were expressed as frequencies (percentages). A Student t test or
Mann-Whitney U test was used for intergroup comparisons of quan-
titative variables where appropriate, whereas a x2 test or Fisher’s exact
test was used to compare categorical data. Regarding the comparison
of the postoperative outcomes between laparoscopic liver and kidney
donors, a first analysis was performed considering the overall study
population. However, given the noncomparability of the groups, a
second comparisonwas performed usingpropensity scorematching. In
this setting, a logistic regression model was used and propensity score
adjustment was performed on the following preoperative character-
istics: sex, age less than 40years, and obesity as defined by aBMImore
than 28 kg/m2. Using these propensity scores, LDLT patients were
randomly matched to LDKT patients using a 1:1 interval matching
method. Thereafter, the groups were compared for examining cova-
riate balance and whether there were statistical differences in baseline
covariates between groups or not. Finally, after assuring the compa-
rability of the groups, comparison of both CCI and postoperative
complications rates between the 2 groups was performed using a
Mann-Whitney U test for intergroup comparisons of quantitative
variables and the x2 test or Fisher’s exact test as appropriate for
comparison of categorical data. A P value of less than 0.05 was
considered significant. All statistical analyses were performed with
SPSS version 20.0 (SPSS Inc., IBM Corp, Armonk, NY).
RESULTS
Liver Donor Characteristics
A total of 124 live liver donors, including 64 males, underwent
LLLS. Their characteristics are given in Table 1. Donors were mostly
father (n¼ 63) or mother (n¼ 55) of the recipient, but in 6 cases, they
were aunt (n¼ 2), uncle (n¼ 2), older sister (n¼ 1), or family friend
(n¼ 1). Conversion to open surgery was necessary in 4 liver donors
due to left portal vein injury (n¼ 1), failure to recognize the left
portal vein (n¼ 1), and failure to progress during transection (n¼ 2).
No liver donor received allogeneic red blood cell transfusion.
Liver Donors Complications
No donor died. Twenty-one complications (17.9%) occurred,
including 9 grade I, 6 grade II, and 6 grade III. These complications
are detailed in Table 2.
Four donors (3%) required reoperation. Two of them had bile
leak due to metal clip dislodgement either from the stump of the left
bile duct (n¼ 1) or segment I bile duct (n¼ 1). Both of them were
operated by redo laparoscopy with suture of the bile duct opening and
they had uneventful postoperative course. One donor had suprapubic
hematoma that required surgical drainage. The last complication was
hematuria and pelvic pain. Cystoscopy showed a transfixing suture in
the bladder wall resulting from closure of the suprapubic incision.
The suture was removed during the same cystoscopic procedure with
no further complications.
Kidney Donors Complications
No donor died. Ninety-five complications (31.7%) occurred,
including 22 grade I, 52 grade II, 5 grade IIIa, and 16 grade IIIb.
These complications are detailed in Table 3.
Liver and Kidney Donors Comparative
Complications
Comparative postoperative outcomes of liver and kidney
donors are given in Table 4. Raw analysis showed a significantly
lower number of minor complications in liver donors, as compared
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with kidney donors, but the rates of major complications were not
significantly different between the 2 groups. A comparable CCI was
observed between liver and kidney donors with complications. The
same comparison was performed after propensity score analysis with
matching on age, sex, and BMI. The liver and kidney groups of 58
donors each were compared and data are given in Table 5. CCI
remained similar between liver and kidney donors with compli-
cations after matching.
Results in Children Recipients
All liver grafts were transplanted and no primary nonfunction
occurred. The 90-day mortality rate was 3.1%: 4 recipients died from
sepsis. Five children required retransplant because of arterial throm-
bosis (n¼ 4) or portal vein thrombosis (n¼ 1).
DISCUSSION
The present study is the first comparative assessment of
morbidity following laparoscopic living donor left lateral sectionec-
tomy for pediatric liver transplantation. We chose LDN as a control
group, as it is the most commonly performed live donor surgery and
is considered the gold standard in most centers.12 Analysis of post-
operative outcomes of 124 LLLS for A-C LDLT showed an overall
morbidity lower than those observed after LDN. Morbidity consisted
mainly in minor complications (grade 1 to 2), while the rates of major
complications were very low (<10%) and identical in both groups.
The CCI, used as the primary end point, has the advantage to take into
account all complications in a given patient.16 It was lower in the
liver donors but identical in both groups when considering only
patients with complications. These results were confirmed after
matching for age, sex, and BMI. We believe our study demonstrates
that LLLS for A-C LDLT is at least as safe as LDN.
LDN is considered a straightforward procedure, as 1 whole
kidney is removed with its own pedicle and ureter, and without the
need for parenchymal transection. By contrast, LDH requires recov-
ery of partial vascular and biliary pedicles as well as parenchymal
transection. The complexity of the procedure, the perceived risk of
donor complications, and the relatively small number of indications
for pediatric liver transplantation have slowed down the development
of the laparoscopic approach. These issues raised persisting concerns
about donor safety and graft integrity, and prevented the laparoscopic
approach to be considered a validated alternative to the open
procedure.
Since the first report in 2002 (5), LDH has remained limited to
few centers, most of which contributed to this study. In a recent
TABLE 1. Characteristics of 124 Liver Donors and Left Lateral
Section Grafts
Age, median (range), years 33.3 (17–57)
Sex, n (%)
Male 64 (51.6)
Female 60 (48.4)
BMI, median (range), kg/m2 23.6 (16–35.5)
ASA score
1 112 (90)
2 12 (10)
3–6 0
Relationship to recipient, n (%)
Father 63 (50)
Mother 55 (45)
Other 6 (5)
Surgery duration, median (range), min 308 (180–555)
Conversion to open approach, n (%) 5 (4)
Estimated blood loss, median (range), cc 50 (10–500)
Liver graft weight, median (range), gm 250 (118–450)
Number of arterial branches, n (%)
1 116 (93)
2 8 (7)
Number of bile ducts, n (%)
1 103 (83)
2 21 (17)
Number of cases per center, n (%)
Paris, France 64 (52)
Seoul, Korea 25 (20)
New York, United States 16 (13)
Lyon, France 13 (10)
Ghent, Belgium 6 (5)
ASA indicates American Society of Anesthesiologists; BMI, body mass index.
TABLE 2. Details of Postoperative Complications in Liver
Donors
Clavien–Dindo
Classification Type of Complication
Number of
Patients
Grade 1 Suprapubic hematoma 3
Gastric ulcer 1
Occipital alopecia 1
Pneumothorax without drainage 1
Wound infection 1
Ileus 1
Arm neuropraxia 1
Grade 2 Gastroparesia 2
Pulmonary infection 1
Segment IV infarction 1
Pneumothorax without drainage 1
Right anterior bile duct stenosis 1
Grade 3
Grade 3a Fluid collection 1
Bladder injury 1
Grade 3b Suprapubic hematoma 1
Bile leakage 3y
Grade 4–5 — 0
Requiring reoperation.
yTwo patients required reoperation and 1 patient was treated using endoscopic
retrograde cholangiography with stenting.
TABLE 3. Details of Postoperative Complications in Kidney
Donors
Clavien-Dindo
Classification Type of Complication
Number of
Patients
Grade 1 Wound hematoma/seroma 5
Prolonged nausea 5
Pain 1
Diarrhea 2
Postoperative ileus 2
Testicular pain 7
Grade 2 Surgical site infection 22
Pulmonary infection 10
Urinary tract infection 11
New hypertensive treatment 7
Blood transfusion 1
Erythema 1
Grade 3
Grade 3a Fluid collection 5
Grade 3b Wash out 13
Appendectomy 2
Splenectomy 1
Grade 4–5 — 0
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publication, we reported the results of 70 cases and described the
development of the laparoscopic technique from the feasibility in the
first cases to the development of a program in a single center.9 This
study included LLLS and some left hepatectomies for adult recip-
ients. The major limitation of this series was the absence of a control
group, explaining why the Jury of the Morioka Consensus Confer-
ence considered the level of evidence as low, and called for more
robust data about short and long-term outcomes. This prompted us to
conduct the current study aiming at benchmark comparison between
LDH from 5 institutions and LDN.
Various approaches to LDN (open, laparoscopic, and hand-
assisted) are considered standard practice.12 The laparoscopic tech-
nique is, however, the recommended technique because it is associ-
ated with decreased blood loss, less postoperative pain, and shorter
length of stay in hospital than after open technique, as shown in meta-
analyses of randomized studies.13,14
After 2 consensus conferences, it is now well-accepted that
laparoscopic minor liver resections for tumors are safe and reprodu-
cible.10,20 Despite the absence of randomized trial, the high number
of published cases and the encouraging results associated with the
laparoscopic versus the open approach on many endpoints have
convinced the independent jury of the second Consensus conference
about the potential advantages of laparoscopy. Several meta-analyses
of case-matched studies have shown that laparoscopic liver resection
for tumors exhibit several advantages over open procedures, such as
reduced blood loss, decreased morbidity, and shorter recovery
times.21,22 In a recent publication, a systematic review with meta-
analysis of LDH found no difference in donor safety between
minimally invasive and open approaches, and found lower blood
loss associated with LLLS for pediatric transplant.23 This decreased
blood loss is of special interest in live donors, as it has been shown
that blood loss is associated with an increase in overall morbidity.24
Accurate figures on perioperative mortality are difficult to
assess in the absence of currently available international registry for
laparoscopic liver surgery, and the low number of LDH procedures
performed to date. For live kidney donation, the 90-day mortality rate
was 3.1 per 10,000 donors in the largest national registry of more than
80,000 donors reported from the USA.25 A few reports have tried to
estimate the mortality rates associated with open surgery for liver
donation through international investigations and systematic reviews
of published fatalities.26,27 The estimated mortality rates ranged
between 0.05% and 1%, with a possible actual rate of 0.1% to
0.5%. The vast majority of fatalities resulted from right hemiliver
donation suggesting that the risk of death correlates with the amount
of resected hepatic tissue, and thus is significantly higher for right
hemiliver donation than for limited left lateral sectionectomy.
TABLE 4. Characteristics and Postoperative Outcomes of Liver and Kidney Donors
Liver Donors (n¼ 124) Kidney Donors (n¼ 300) P
Sex male, n (%) 64 (51.6) 141 (47.0) 0.387
Age, median (range), years 33.3 (17–57) 47.6 (18–76) <0.001
BMI, median (range), kg/m2 23.6 (16–35.5) 26.0 (16.8–36.3) <0.001
Hypertension, n (%) 1 (0.8) 36 (12) <0.001
ASA score >1, n (%) 12 (9.7) 93 (31.0) <0.001
Conversion to open surgery, n (%) 5 (4.0) 1 (0.3) 0.003
Surgery duration, median (range), min 308 (180–555) 177 (64–406) <0.001
Complications, n (%) 21 (16.9) 95 (31.7) 0.002
Minor complications 15 (12.1) 74 (24.7) 0.004
Major complications 6 (4.8) 21 (7.0) 0.407
CCI all patients 3.3 (0–33.7) 6.9 (0.0–78.0) 0.002
CCI patients with complications 19.3 (8.7–33.7) 21.9 (8.7–78.0) 0.290
Hospital stay, median (range), days 6.3 (2–18) 5.6 (2–23) 0.010
ASA indicates American Society of Anaesthesiologists; BMI, body mass index; CCI, comprehensive complication index.
TABLE 5. Characteristics and Postoperative Outcomes of Liver and Kidney Donors After Propensity Score Matching
Liver Donors (n¼ 58) Kidney Donors (n¼ 58) P
Male sex, n (%) 20 (34.5) 20 (34.5) 
Age, mean (range) years 31.7 (18–39.6) 31.9 (18.7–39.9) 0.748
Age <40 years, n (%) 58 (100) 58 (100) 
BMI, median (range) kg/m2 23.4 (16.0–35.5) 23.9 (16.9–35.2) 0.741
BMI <28, n (%) 43 (74.1) 43 (74.1) 
ASA <2, n (%) 58 (100) 58 (100) 1.000
Hypertension, n (%) 1 (1.7) 2 (3.4) 0.558
Conversion to open surgery, n (%) 2 (3.4) 1 (1.7) 0.558
Surgery duration, median (range) min 320 (180–555) 176 (80–376) <0.001
Complication, n (%) 7 (12.1) 22 (37.9) 0.001
Minor complication 4 (6.9) 14 (24.1) 0.001
Major complication 3 (5.2) 8 (13.8) 0.113
CCI all patients, median (range) 2.1 (0.0–33.7) 9.4 (0.0–33.7) <0.001
CCI patients with complication, median (range) 19.9 (8.7–33.7) 23.9 (8.7–33.7) 0.357
Hospital stay, median (range), days 6.5 (2–14) 5.4 (2–11) 0.019
Variables used for propensity score matching.
ASA indicates American Society of Anaesthesiologists; BMI, body mass index; CCI, comprehensive complication index.
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In the current international series of LLLS, we observed zero
mortality but an overall morbidity rate of 17%, including 5% of major
complications. These figures are comparable to those described in
previous reports after open surgery.28 Two types of complications from
our series need, however, to be highlighted. First, 4 patients developed
biliary complications, representing a 3% incidence, which is in the
usual range reported in open live donor hepatectomy.24,28 Two were
major ones due to a dislodged clip and required redo laparoscopy.
These 2 cases occurred early in the most experienced center and bile
leaks were no longer observed after the use of secured clips or stitches.
Second, 5 (4%) complications were related to the Pfannenstiel
incision: 4 hematomas, including 1 requiring drainage, and 1 bladder
trauma due to suture transfixion during abdominal wall closure. These
serious complications emphasize the need for special attention to
extraction incisions in laparoscopic surgery. Again, all 4 occurred
early in the experience and have not been observed since.
Recipient and graft outcomes were not the purpose of this
study, but as summarized in Table 1, the number of grafts arteries and
bile ducts were in the normal range of open series and patient and
graft survival were previously studied and found identical to those
reported with open surgery.7,9
This study has several limitations. First, comparing morbidity
of 2 different entities of surgery might seem inappropriate. However,
this was a deliberate choice aiming at benchmarking LDH by
comparison with the well-accepted LDN. Our study was made
possible by the careful prospective recording of all adverse events,
including minor morbidity, allowing calculation of the CCI in both
liver and kidney donors, making it a solid comparison. A second
limitation is that liver cases originated from highly specialized
centers. However, the multicentric participation from various
countries demonstrates the reproducibility of the procedure in the
hands of trained surgeons. The final limitation is the retrospective
nature of the study. Although a randomized controlled trial compar-
ing open versus LLLS in live donors should be performed, the low
number of pediatric LDLT prevents the feasibility of a meaningful
study. In the current study, several facts contribute to validate the
procedure: the large number of cases showing at least identical safety
of the LDH with standard LDN, the multicentric participation from
various countries, and finally the use of a very sensitive marker of
complications, the CCI, which has already demonstrated to
strengthen comparisons and increase sensitivity.19,29
In conclusion, this study provides the first validation of LDH
and suggests that laparoscopy, along with the open approach, should
become, similarly to LDN, a standard practice for retrieval of left
lateral section liver grafts in live donors. More data about the short
and long-term outcomes in both donor and recipient should be
obtained in the future through international registries to better
determine the benefit/risk ratio of this laparoscopic procedure.
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DISCUSSANTS
J.C. Garcı´a-Valdecasas Salgado (Barcelona, Spain):
Thank you very much for giving me the opportunity to review
this article.
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This is an interesting study, although retrospectively it has
the value to have been performed by highly recognized surgical
groups. I have to recognize that it has taken me time to understand
the rationale of the study. The authors recognized that even though it
is lacking an adequate control group, they decide to compare
retrospectively 2 totally different procedures by using the recently
described CCI. By doing so, the authors are able to show that the
risk of LLLS is similar to a well-established and accepted standard
of care procedure such as LDN. The authors conclude that as this
is the case, LLLS should be considered the standard of care for adult
to child living donor liver transplantation. The authors have shown
that LLLS is a safe procedure in the hands of highly selective
surgical groups andmay be considered a very good alternative to the
open one. I can only congratulate the group for such outstanding
results.
I have some questions: As a surgeon, I am very interested to
know how the trocars are placed as well as which are the most
frequent positions that are used by the various groups. We often
watch beautiful videos showing the hepatic veins as well as what
seems to be an easy approach to the hilum. However, we keep
forgetting that the positioning of trocars are most important in order
to have such good views.
Was the donor heparinized right before retrieving the organ?
How long did it take from vascular clamping to graft abdominal
extraction (median, range)?
I understand that the advantage of using CCI allows us to
compare a wide range of complications, no matter the type of
procedure. As the authors assumed in the text, LLLS is a procedure
with a significant increased complexity when compared with LDN.
At the same time, the authors suggest the importance of blood loss
during the procedure as a major factor in the incidence of compli-
cations (the reason of the 4 conversions). It is clear that the risk of
bleeding during LDN is significantly lower. The way we perform
liver parenchyma transection is still a matter of controversy. I would
like to know the author’s opinion about the current systems of vessels
sealing and transection devices. Are they good enough, or should we
look for a better system in order to be able to consider a laparoscopic
approach of the liver as the standard of care?
Response From O. Soubrane (Clichy, France):
Thank you very much. Your first question concerned trocar
placement. For this part of the liver, which is the left side, it is quite
easy to mobilize and see the liver with this approach. It is a very
standard position with the optics on the midline, probably just above
the umbilicus and, with the rule of triangulation, 2 operative trocars,
1 on each side, and a fourth and fifth trocar below the sternum and in
the right flank, respectively. This is very usual and probably there is
no big variation among the teams about these trocar positions.
Your second question was about heparin. Unfortunately, this
point was not recorded in the whole database, but I can answer for the
French part of this series. We did not use heparin in the donor before
clamping. We are not very confident when it comes to the use of
heparin during hepatectomy, but we probably should think about it in
the future.
Your third question was about the time necessary to remove
the liver graft and you refer to the risk of warm ischemia. The median
warm ischemic time was 8 minutes and the longest time was 12
minutes. I think this is reasonable and probably does not exceed the
warm ischemia time observed in open surgery. The trocar with the
big bag is already in the abdomen at the time of clamping. This is
going quickly.
Your fourth question is about the risk of bleeding. We now
have more and more devices allowing for a good control of bleeding
and we think that probably the blood loss in laparoscopic liver
surgery is lower and lower. I am not saying that there is no risk
of hemorrhage, but no patient was transfused in this large multi-
centric series. The low level of blood loss is explained by the
pneumoperitoneum pressure and the low CVP. Other factors such
as the position specific for laparoscopic surgery with the head up tilt
and the reverse Trendelenburg may also play a role.
Regarding the devices used to cut the liver, this was a topic
covered by the experts during the last consensus conference last
October in Japan. Most teams use cautery devices to open the
superficial part of the liver followed by the ultrasonic dissector with
aspiration and bipolar coagulation. This kind of device is more and
more sophisticated and you can change the parameters of the
program according to the characteristics of the liver you are cutting.
When you have arrived in the posterior part or near the big hepatic
veins, you may change the program with a softer intensity
of ultrasounds.
H. Bismuth (Paris, France):
Thank you, it is a very interesting study and I have nothing to
say about the study design. My question is more in the forefront of
your work. Some years ago, Xavier Rogers showed us here that
removing the left lobe of a cadaveric graft has no negative effect at all
on the remaining graft to be used for an adult recipient. My question
is: Why do you use a living donor when you can use a cadaveric graft
to be split into 2 transplants for a child and an adult with the same
results? Although this cannot be used in all cases, there are enough
good livers for the need of the pediatric population.
Response From O. Soubrane (Clichy, France):
Thank you Professor Bismuth for your important point. There
are, however, several reasons why we still need living donors. This is
a situation very different than in the adult population. First, even
though we may take advantage of the split procedure, you know that
the deceased donors are not the same as 20 years ago. We have much
older donors and marginal livers such as steatotic grafts, which
cannot be used for children or infants.
Second, there is a strong demand from many families and
parents. Ayoung mother and a young father are sometimes extremely
willing to give their own liver to their child. We must take this into
consideration. At last, there are some convincing data showing that
the best results, including survival rates, are obtained using a liver
graft from a live donor even considering that some teams are still
reluctant because the vessels are short with a higher risk of technical
complication. This is why it is difficult to ignore this approach. We
have gathered for this study case from all over the world to reach a
significant number. Pediatric liver transplantation represents grossly
5% of liver transplants all over the world. Although this might seem
to be a small figure, it still represents many cases for which living
donation is important.
N. Senninger (Mu¨nster, Germany):
First of all, I would like to express my applause to your
surgical skills because doing this operation in a laparoscopic way
requires enormous expertise and obviously you have it. It is, however,
not a pure laparoscopic procedure, although you are doing hepatic
hilar dissection laparoscopically because you have to retrieve the
organ so there is an incision anyway. It is a hybrid procedure, just to
make this clear. I am in a center where we have tested both
approaches for living kidney transplantation, and we, and many
others, still practice the open approach. So, laparoscopic living
kidney harvesting to me cannot be called a gold standard. The
lateral–anterior, purely retroperitoneal incision takes just 60 to
70 minutes time for retrieval, the first warm ischemia time takes
just 20 seconds as compared to 3 to 4 minutes in laparoscopic
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procedures. We have a 100% function rate of the kidneys in the first
year. This cannot be so bad! So, we are not changing our program.
My major concern is that you are comparing 2 operations that are not
comparable. The main comment is that avoiding the event of a donor
death, which is a sentinel event, cannot be called an advantage, as it
should never ever happen. At the moment, I’m waiting for the
scientific proof that we all should do the living related left liver
resection in a laparoscopic way. I am not going to change it according
to your data so far.
Response From O. Soubrane (Clichy, France):
I think, as you said, we compared healthy donors even though
they were not giving the same organ. It was impossible to organize any
other type of comparison, especially no randomized study was think-
able in this setting. The main point of this study is that we could show
using new tools in outcome research that laparoscopic living donor left
sectionectomy is safer than laparoscopic living donor nephrectomy,
and thus, we would suggest that the laparoscopic approach for living
donor left sectionectomy becomes a standard of care.
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